Back

The impact of myocardial volume assessed with cardiac computed tomography on the prediction of coronary lesion ischemia

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Fractional Flow Reserve (FFR) ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Junji Matsuda

Japanese Red Cross Saitama Hospital, Saitama (Japan)

174 More presentations in this session

Presentation thumbnail
Clinical profile and predictors of positivity of acetylcholine test in patients with angina and no obstructive coronary artery disease. Results of a multi-center mediterranean registry.
Doctor L. Grigorian (Madrid, ES)
Abstract Slides
Presentation thumbnail
Comparison of neointimal coverage between biodegradable-polymer everolimus-eluting stent and durable-polymer everolimus-eluting stent using angioscopy for the patients with acute coronary syndrome
Assistant Professor T. Umemoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Global risk factors of contrast-Induced acute kidney injury: systematic review and meta-analysis
Doctor L. Liu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty
Doctor H. Kirigaya (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.
Doctor A. Candreva (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Interventional Cardiology ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Beyond the stenosis: physiological assessment in modern coronary artery disease management
thumbnail
Congress Presentation
Nuclear cardiology is best for risk assessment
thumbnail
Congress Presentation
Real world impact of added FFR-CT to coronary CT angiography on clinical decision-making and patient prognosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources